BIZILY SCOTT (Chief Legal Officer) sold 6.3% of their position (584.00 shares) of 4D MOLECULAR THERAPEUTICS, INC. on the open market
Open‑market sale worth $8.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/3/2026ACC: 0001193125-26-382245
Officer· Chief Legal Officer
Since Mar 2022
-584.00
Net shares
Net seller
$8.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
584.00 acquired · 1.17K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+584.00
Price / share
$6.49
Trade value
$3.79K
% of position
6.8%
9/1/2026
8.62K→9.20K
Common Stock
Direct
Shares
−584.00
Price / share
$14.00
Trade value
$8.18K
% of position
6.3%
9/1/2026
9.20K→8.62K
Total
Net shares
+0.00
Net value
-$4.39K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | M · Option Exercise | +584.00 | $6.49 | $3.79K | 6.8% | 8.62K | 9.20K |
| Common Stock Direct | 9/1/2026 | S · Sale | −584.00 | $14.00 | $8.18K | 6.3% | 9.20K | 8.62K |
| Total | +0.00 | -$4.39K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
584.00 shares
Shares
−584.00
Strike price
6.49
Held after
2.96K
Exercisable
—
9/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock584.00 shares | 9/1/2026 | M · Option Exercise | −584.00 | 6.49 | — | 2.96K |